Churchill Management Corp Cuts Stake in Pfizer pfe by 906 in Q1 Sec Filing

Churchill Management Corp Cuts Stake in Pfizer (PFE) by 90.6% in Q1: SEC Filing

In a recent disclosure with the Securities & Exchange Commission, it has been revealed that Churchill Management Corp, a notable institutional investor, has trimmed its stake in the biopharmaceutical giant Pfizer Inc. (NYSE: PFE) by a staggering 90.6% during the first quarter. This means that the company now owns only 33,472 shares of Pfizer, a significant drop from its previous stake of 355,692 shares.

This drastic change has resulted in a significant decrease in Churchill Management Corp’s holdings in Pfizer Inc., which now amount to $1,366,000 ($1.36 million). While some investors might find this reduction concerning, it’s important to keep in mind that such changes are not uncommon in the stock market and should be considered from a broader perspective.

Meanwhile, Pfizer has announced a quarterly dividend payment. The dividend is scheduled to be paid on Tuesday, September 5th. This dividend payment will be issued to stockholders of record on Friday, July 28th, and represents $0.41 per share -a substantial yield relative to many other stocks- equating to an annualized dividend payout ratio of $1.64 and 4.28%.

In addition, Director Scott Gottlieb has made a significant purchase of Pfizer stock. On May 8th of this year, Gottlieb acquired 1000 shares at an average price of $38.58 per share. Following this acquisition, he now owns a total of 6000 shares, valued at $231,480 million. This move indicates Gottlieb’s optimistic outlook on the company’s growth potential.